Resveratrol: preventing properties against vascular alterations and ageing.
Cardiovascular diseases are the leading cause of death in developed countries where the common pathological substrate underlying this process is atherosclerosis. Several new concepts have emerged in relation to mechanisms that contribute to the regulation of the vascular diseases and associated inflammatory effects. Recently, potential antioxidants (vitamin E, polyphenols) have received much attention as potential anti-atherosclerotic agents. Among the polyphenols with health benefic properties, resveratrol, a phytoalexin of grape, seem to be a good candidate protecting the vascular walls from oxidation, inflammation, platelet aggregation, and thrombus formation. In this review, we focus on the mechanism of resveratrol cardiovascular benefic effects. We analyze, in relation with the different steps of atherosclerotic process, the resveratrol properties at multiple levels, such as cellular signaling, enzymatic pathways, apoptosis, and gene expression. We show and discuss the relationship with reactive oxygen species, regulation of pro-inflammatory genes including cycloxygenases and cytokines in molecular inflammatory and aging processes, and how the regulation of these activites by resveratrol can lead to a prevention of vascular diseases.
Delmas
Dominique
D
University of Burgundy, Laboratory of Molecular and Cell Biology, Dijon, France.
Jannin
Brigitte
B
Latruffe
Norbert
N
D000375:Aging; D001161:Arteriosclerosis; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D005487:Foam Cells; D006293:Health Promotion; D006801:Humans; D008074:Lipoproteins / Q000097:blood; D008264:Macrophages; D009131:Muscle, Smooth, Vascular; D009389:Neovascularization, Pathologic; D018384:Oxidative Stress; D010974:Platelet Aggregation; D000077185:Resveratrol; D013267:Stilbenes / Q000008:administration & dosage*; D014664:Vasodilation
D008074:Lipoproteins; D013267:Stilbenes; D000077185:Resveratrol